KR890001582A - Countercurrent - Google Patents

Countercurrent Download PDF

Info

Publication number
KR890001582A
KR890001582A KR1019870006894A KR870006894A KR890001582A KR 890001582 A KR890001582 A KR 890001582A KR 1019870006894 A KR1019870006894 A KR 1019870006894A KR 870006894 A KR870006894 A KR 870006894A KR 890001582 A KR890001582 A KR 890001582A
Authority
KR
South Korea
Prior art keywords
represented
general formula
pharmaceutical composition
modified arthritis
neolactone
Prior art date
Application number
KR1019870006894A
Other languages
Korean (ko)
Other versions
KR940006324B1 (en
Inventor
다까히로 오찌
Original Assignee
오오쓰가 아끼히꼬
오오쓰까 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오오쓰가 아끼히꼬, 오오쓰까 세이야꾸 가부시끼가이샤 filed Critical 오오쓰가 아끼히꼬
Priority to KR1019870006894A priority Critical patent/KR940006324B1/en
Publication of KR890001582A publication Critical patent/KR890001582A/en
Application granted granted Critical
Publication of KR940006324B1 publication Critical patent/KR940006324B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음No content

Description

향류머티스제Countercurrent

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (6)

하기 일반식(1)로 표시되는 글리코리피트를 투여하는 변형 관절염의 치료 방법.A method for treating modified arthritis by administering glycolipite represented by the following general formula (1). [상기식중, n은 1또는 2이다.][Wherein n is 1 or 2] 제1항에 있어서, 상기 일반식(1)로 표시되는 를리코이프드가 디푸코실 네오락토르헥사오실세라미드(식중, n은 1이다)인 변형 관절염의 치료 방법.The method of treating modified arthritis according to claim 1, wherein the lycopide represented by the general formula (1) is difucosyl neolactorhexaosylceramide (wherein n is 1). 제1항에 있어서, 상기 일반식(1)로 표시되는 를로코이피드가 트리푸코실 네오락토르옥라타오실세라미드(식중, n은 2이다)인 변형 관절염의 치료방법.The method for treating modified arthritis according to claim 1, wherein the rocoid feed represented by the general formula (1) is trifucosyl neolactorolataosylceramide (where n is 2). 하기 일반식(1)로 표시되는 글리코리피드를 활성성분으로서 함유하는 변형 관절염 치료용 약제학적 조성물.A pharmaceutical composition for the treatment of modified arthritis, containing glycolipide represented by the following general formula (1) as an active ingredient. [상기식중, n은 1또는 2이다.][Wherein n is 1 or 2] 제4항에 있어서, 상기 일반식(1)로 표시되는 를리코리피드가 디푸코실 네오락토노르헥사오실세라미드(식중, n은 1이다)인 약제학적 조성물.The pharmaceutical composition according to claim 4, wherein the lycolipid represented by the general formula (1) is difucosyl neolactone norhexaosylceramide (where n is 1). 제4항에 있어서, 상기 일반식(1)로 표시되는 글리피드가 트리푸코실 네오락토노르옥타오실세라미드(식중, n은 2이다)인 약제학적 조성물.The pharmaceutical composition according to claim 4, wherein the glyfeed represented by the general formula (1) is trifucosyl neolactone noroctaosyl ceramide (wherein n is 2). ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019870006894A 1987-07-01 1987-07-01 Antirheumatic agent KR940006324B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019870006894A KR940006324B1 (en) 1987-07-01 1987-07-01 Antirheumatic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019870006894A KR940006324B1 (en) 1987-07-01 1987-07-01 Antirheumatic agent

Publications (2)

Publication Number Publication Date
KR890001582A true KR890001582A (en) 1989-03-27
KR940006324B1 KR940006324B1 (en) 1994-07-16

Family

ID=19262583

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870006894A KR940006324B1 (en) 1987-07-01 1987-07-01 Antirheumatic agent

Country Status (1)

Country Link
KR (1) KR940006324B1 (en)

Also Published As

Publication number Publication date
KR940006324B1 (en) 1994-07-16

Similar Documents

Publication Publication Date Title
KR900007837A (en) Quinuclidin, its use as a medicament and method for preparing the same
UA41446C2 (en) Use of fumagilol or its derivatives for preparing drugs intended for treating intestinal infection and pharmaceutical composition
HUT50786A (en) Process for producing new condensed heterocyclic compounds and pharmaceutical compositions containing them as active components
DK0421561T3 (en) 24-homo-vitamin D derivatives, processes for their preparation, pharmaceutical compositions containing these derivatives and their use as a drug
KR890015742A (en) Topical preparations for the treatment of diseases
SE8600632D0 (en) NOVEL PHARMACEUTICAL COMPOSITION
KR880013555A (en) How to Treat Diabetes
KR910021361A (en) Anti-ulcer substance
KR880007070A (en) Pharmaceutical composition for cataract treatment
KR900003174A (en) Benzofuro [3,2-C] quinoline compound
KR890003373A (en) Use of compounds to treat sleep disorders and depression
KR890001582A (en) Countercurrent
KR880012226A (en) External agent
KR890001540A (en) Heart Failure Treatment
KR880009656A (en) Treatment or prophylaxis of local periodontal disease
KR880009644A (en) Weak composition for treating ulcerative bowel disease
KR870010036A (en) Process for preparing organozinc complex and pharmaceutical composition containing same as active ingredient
KR920016021A (en) Animal development promoting or improving feed and methods
KR920019349A (en) Use of R (+)-3-amino-1-hydroxy-pyrrolidin-2-one to treat anxiety
KR890001543A (en) Diabetes treatment
KR890017363A (en) Strobiliurin derivatives, their preparation and uses
KR880013936A (en) Strong tricyclic imidazolone
FI903701A0 (en) RENINHAEMMANDE AMINO-OLIGOHYDROXIDERIVAT.
KR900017599A (en) Pharmaceutical composition for tumor treatment
KR880000094A (en) Gastritis Treatment

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19990705

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee